LATEST
Silgan / Trivium: minority stakeBF International Best Fields Best Food / DiagramOpenWorld agreed to acquire Blocksight HoldingsMerck KGaA agreed to acquire Silence TherapeuticsLarry A. Powalisz / Adia LabsTTM Technologies / Ophir® Optics businessTradeweb Markets agreed to acquire Trumid HoldingsCentrus Energy / Westerman HoldingsTCGX Acquisition / TriGemX BioArlington Capital Partners / Gooch & HousegoJanus Henderson Investors agreed to acquire four mutual funds managed by Nicholas CompanyPlatinum Equity / Trime: majority stake
Open App
ClosedPublished 18 Mar 2024

Bristol-Myers Squibb /
Karuna

Bristol-Myers Squibb completes merger with Karuna

Buy side: Bristol-Myers Squibb
Buy sideBristol-Myers Squibb
Target: Karuna
TargetKaruna
Source · 18 Mar 2024Source-verified
See the source
Buy side: Bristol-Myers Squibb
Buy sideBristol-Myers Squibb
Target: Karuna
TargetKaruna
01 / BuyerBristol-Myers Squibb
02 / TargetKaruna
Source-verified
01

What happened

Bristol-Myers Squibb completed its merger with Karuna on March 18, 2024. Karuna is now a wholly owned subsidiary of Bristol-Myers Squibb.

Eligible shares of Karuna common stock were converted into the right to receive $330 in cash per share.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Bristol-Myers Squibb completes merger with Karuna

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

    Source-verified

  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.